Drug profile · INN
cefiderocol sulfate tosylate
FETROJA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cefiderocol sulfate tosylate (FETROJA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN cefiderocol sulfate tosylate
Brand FETROJA
Route INTRAVENOUS
Formulation POWDER
Frequently asked questions
What is cefiderocol sulfate tosylate?
cefiderocol sulfate tosylate (FETROJA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for cefiderocol sulfate tosylate?
FETROJA is a marketed brand name for cefiderocol sulfate tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefiderocol sulfate tosylate?
cefiderocol sulfate tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.